INS and myocardial infarction: Patients with type 2 diabetes and acute myocardial infarction were randomized to one of the two treatment strategies: one treatment strategy that targeted postprandial glycemia (administration of insulin lispro) and another that targeted fasting/interprandial glycemia (administration of basal insulin or biphasic intermediate-acting insulin).